Rationally designed peptide regulators of protein kinase C

被引:79
作者
Churchill, Eric N. [1 ]
Qvit, Nir [1 ]
Mochly-Rosen, Daria [1 ]
机构
[1] Stanford Univ, Sch Med, Dept Chem & Syst Biol, Stanford, CA 94305 USA
基金
美国国家卫生研究院;
关键词
IMMUNODEFICIENCY-VIRUS TYPE-1; REGION-DERIVED PEPTIDES; BACKBONE CYCLIC PEPTIDE; PKC-BETA-II; INTRACELLULAR RECEPTORS; BIOLOGICAL-ACTIVITY; AMINO-ACID; DELTA-PKC; THERAPEUTIC TARGETS; REPERFUSION INJURY;
D O I
10.1016/j.tem.2008.10.002
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Protein-protein interactions sequester enzymes close to their substrates. Protein kinase C (PKC) is one example of a ubiquitous signaling molecule with effects that are dependent upon localization. Short peptides derived from interaction sites between each PKC isozyme and its receptor for activated C kinase act as highly specific inhibitors and have become available as selective drugs in basic research and animal models of human diseases, such as myocardial infarction and hyperglycemia. Whereas the earlier inhibitory peptides are highly specific, we believe that peptides targeting additional interactions between PKC and selective substrates will generate even more selective tools that regulate different functions of individual isozymes. Here, we discuss the methodologies and applications for identifying selective regulators of PKC.
引用
收藏
页码:25 / 33
页数:9
相关论文
共 122 条
[1]   Pharmacological profiles of peptide drug candidates for the treatment of Alzheimer's disease [J].
Adessi, C ;
Frossard, MJ ;
Boissard, C ;
Fraga, S ;
Bieler, S ;
Ruckle, T ;
Vilbois, F ;
Robinson, SM ;
Mutter, M ;
Banks, WA ;
Soto, C .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2003, 278 (16) :13905-13911
[2]  
AITKEN A, 1990, NATURE, V344, P594
[3]   Backbone cyclic peptide antagonists, derived from the insect pheromone biosynthesis activating neuropeptide, inhibit sex pheromone biosynthesis in moths [J].
Altstein, M ;
Ben-Aziz, O ;
Daniel, S ;
Schefler, I ;
Zeltser, I ;
Gilon, C .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1999, 274 (25) :17573-17579
[4]   Direct binding and activation of protein kinase C isoforms by aldosterone and 17β-estradiol [J].
Alzamora, Rodrigo ;
Brown, Laura R. ;
Harvey, Brian J. .
MOLECULAR ENDOCRINOLOGY, 2007, 21 (11) :2637-2650
[5]   Peptidomimetics - Antagonists of the fibrinogen receptors: Molecular design, structures, properties and therapeutic applications [J].
Andronati, SA ;
Karaseva, TL ;
Krysko, AA .
CURRENT MEDICINAL CHEMISTRY, 2004, 11 (09) :1183-1211
[6]  
[Anonymous], 1894, Berichte der deutschen chemischen Gesellschaft
[7]   Small-molecule inhibitors of protein-protein interactions: Progressing towards the dream [J].
Arkin, MR ;
Wells, JA .
NATURE REVIEWS DRUG DISCOVERY, 2004, 3 (04) :301-317
[8]  
AYALA A, 2007, NOVART FDN SYMP, V49, P160
[9]   Molecular dynamics characterization of the C2 domain of protein kinase Cβ [J].
Banci, L ;
Cavallaro, G ;
Kheifets, V ;
Mochly-Rosen, D .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2002, 277 (15) :12988-12997
[10]   Backbone metal cyclization:: novel 99mTc labeled GnRH analog as potential SPECT molecular imaging agent in cancer [J].
Barda, Y ;
Cohen, N ;
Lev, V ;
Ben-Aroya, N ;
Koch, Y ;
Mishani, E ;
Fridkin, M ;
Gilon, C .
NUCLEAR MEDICINE AND BIOLOGY, 2004, 31 (07) :921-933